Same ingredient, two names · liraglutide
Saxenda vs Victoza
From the two FDA labels, read Published by PepVault
Saxenda and Victoza are the same medicine, liraglutide, under two names from Novo Nordisk.
What differs is the label. FDA approved Saxenda for weight loss and keeping it off, in adults and in children 12 and older with obesity. Victoza is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes and heart disease.
Label against label
| Compared | Saxenda | Victoza |
|---|---|---|
| Active ingredient | liraglutide | liraglutide |
| Class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Maker | Novo Nordisk | Novo Nordisk |
| Approved for | Weight reduction (adults and children 12 and up) | Type 2 diabetes (adults and children 10 and up); heart risk |
| Forms | Prefilled pen | Prefilled pen |
| How often | once a day | once a day |
| Starting dose | 0.6 mg a day | 0.6 mg a day |
| Top dose on the label | 3 mg a day | 1.8 mg a day |
| Most reported side effect | Nausea, 39.3% on Saxenda (placebo 13.8%) | Nausea, 20% on 1.8 mg (placebo 5%) |
| Boxed warning | “RISK OF THYROID C-CELL TUMORS” | “RISK OF THYROID C-CELL TUMORS” |
| First approved | 2014 | 2010 |
Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.
The two dosing schedules
This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.
Saxenda, once a day
Victoza, once a day (adults)

A missed dose, on each label
The research on the ingredient
Questions
Are Saxenda and Victoza the same drug?
They hold the same active ingredient, liraglutide, from Novo Nordisk. They are approved for different uses and come in different forms and doses.
What are Saxenda and Victoza approved for?
Saxenda is approved for weight loss and keeping it off, in adults and in children 12 and older with obesity. Victoza is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes and heart disease.
How often are Saxenda and Victoza taken?
Saxenda is taken once a day, as an injection; Victoza once a day, as an injection.
What are the dose ranges of Saxenda and Victoza?
On their labels, Saxenda runs 0.6 mg to 3 mg once a day, and Victoza 0.6 mg to 1.8 mg once a day. A prescriber sets the actual dose.
What is the most common side effect of Saxenda and Victoza?
On Saxenda’s label: nausea, 39.3% on Saxenda (placebo 13.8%). On Victoza’s: nausea, 20% on 1.8 mg (placebo 5%).
Sources
- SAXENDA (liraglutide) injection, for subcutaneous use, FDA label on DailyMed (version 22, published Jun 15, 2026; read Nov 18, 2026)
- VICTOZA (liraglutide) injection, for subcutaneous use, FDA label on DailyMed (version 31, published Nov 17, 2025; read Nov 18, 2026)
- Drugs@FDA, NDA 206321 (Saxenda, the injection; application first approved 2014)
- Drugs@FDA, NDA 022341 (Victoza, the injection; application first approved 2010)
PepVault is not affiliated with Novo Nordisk. Saxenda is a trademark of its owner. Victoza is a trademark of its owner.